| Business Summary |
| The Company designs, develops, manufactures and markets an implantable medical device that provides vagus nerve stimulation therapy for the treatment of refractory epilepsy and treatment-resistant depression. |
| General Information |
100 Cyberonics Bouelvard
Houston, TX 77058
|
| www.cyberonics.com |
| Industry : Health Services |
| Sector: Health Care |
| Employees: 440 |
| CEO: Daniel Jeffrey Moore |
| Short Interest |
| Current Month (Mil) |
2.66 |
| Previous Month (Mil) |
2.58 |
| Short Interest Ratio (Days) |
26.50 |
| Management Effectiveness |
| Return on Equity |
85.00 |
| Return on Assets |
49.20 |
| Return on Investments |
58.70 |
| Profitability |
| Gross Margin |
87.20 |
| EBIT Margin |
24.10 |
| Profit Margin |
48.60 |